NCT05226364

Brief Summary

This prospective study evaluates the effect of abstaining from tourniquets on pain reduction during the venous puncture of the elderly people.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 7, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

May 18, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 11, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 11, 2024

Completed
Last Updated

December 31, 2024

Status Verified

December 1, 2024

Enrollment Period

2.2 years

First QC Date

December 15, 2021

Last Update Submit

December 30, 2024

Conditions

Keywords

Venous PunctureTourniquetPainElderly people

Outcome Measures

Primary Outcomes (1)

  • Comparison of the maximum pain associated with venous puncture, in elderly patients with a visible or palpable vein depending on the method of sampling.

    Assessment of maximum pain on examination (including pain from skin-vascular invasion and tourniquet pain)by the patient using a verbal numerical scale (EN) rated from 0 to 10. This measure concerns the 1st sampling as a whole, regardless of the number of attempts necessary to obtain it and their terms

    At the end of the study, an average of 12 month

Secondary Outcomes (12)

  • Proportion of elderly patients with a visible or palpable vein

    At the end of the study, an average of 12 month

  • Comparison of the number of cutaneous-vascular breaks necessary for obtain a blood sample, according to the venous sampling procedure

    At the end of the study, an average of 12 month

  • Comparison of the time taken to obtain a blood sample by caregivers, according to the venous sampling procedures

    At the end of the study, an average of 12 month

  • Comparison of the ease of taking the sample by caregivers, according to the venous sampling procedure

    At the end of the study, an average of 12 month

  • Estimation of the pain due to the tourniquet and to the cutaneous-vascular breaks in patients where sample was taken with tourniquet

    At the end of the study, an average of 12 month

  • +7 more secondary outcomes

Study Arms (3)

Rubber tourniquet

EXPERIMENTAL

The blood sample is taken with a rubber tourniquet,

Procedure: Rubber tourniquet

Fabric tourniquet

EXPERIMENTAL

The blood sample is taken with a a fabric tourniquet

Procedure: Fabric tourniquet

No tourniquet

EXPERIMENTAL

The blood sample is taken without tourniquet

Procedure: Without tourniquet

Interventions

The blood sample is taken with a rubber tourniquet

Rubber tourniquet

The blood sample is taken with a fabric tourniquet

Fabric tourniquet

The blood sample is taken without tourniquet

No tourniquet

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • ≥ 75 years and over,
  • Hospitalized in internal medicine or geriatric department,
  • For which the 2 upper limbs are accessible to venous puncture (due to the multiple attempts that may be necessary to take a sample during the hospitalization),
  • For which at least one vein is visible or palpable on an upper limb,
  • Without venous puncture since admission in the department,
  • Patient who did not receive a topical anesthetic before the venous puncture (Emla type)
  • Communicating patient, able to assess their pain on a digital scale,
  • Patients with affiliation to a social security system or beneficiary ,
  • Written informed consent (IC) obtained.

You may not qualify if:

  • Patient already included,
  • Previous pain localized to the upper limbs,
  • Hematoma at the planned site of skin-vascular breakage,
  • Hemiplegic or quadriplegic patient,
  • Patient with lymphedema in the upper limbs,
  • Patient with behavioral disorders that may interfere with the proper functioning of the sampling,
  • Patient with cognitive impairment preventing understanding of the study and adequate assessment pain (CODEX cognitive score of category C or D),
  • Patient placed under legal protection (guardianship).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Geriatric Department - CHRU Brest

Brest, 29600, France

Location

Geriatric Department - CH Cholet

Cholet, 49 300, France

Location

Geriatric Department - Hospital Louis Mourier - Colombes

Colombes, 92700, France

Location

Geriatric Department - Intercommunal hospital center - Créteil

Créteil, 94010, France

Location

Geriatric Department - Hospital René Dubos - Pontoise

Pontoise, 95300, France

Location

MeSH Terms

Conditions

Pain

Interventions

Tourniquets

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Officials

  • Vella QUILLIEN

    Hospital René Dubos - Pontoise

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2021

First Posted

February 7, 2022

Study Start

May 18, 2022

Primary Completion

July 11, 2024

Study Completion

July 11, 2024

Last Updated

December 31, 2024

Record last verified: 2024-12

Locations